A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00096837
Recruitment Status : Completed
First Posted : November 17, 2004
Last Update Posted : June 8, 2006
Information provided by:
Pharmacyclics LLC.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : No date given